Literature DB >> 2033136

Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases.

C Garbe1, H Stein, D Dienemann, C E Orfanos.   

Abstract

Four patients with low-grade malignant B cell lymphoma of the skin in association with chronic Borrelia burgdorferi infection are presented. Plaque-shaped or nodular erythematous lesions with ill-defined borders were seen. Clinical progression was slow; the skin tumors occurred for up to 7 to 15 years. Extracutaneous involvement was found in only one case. Immunohistologic investigations showed an expression of B cell markers with restriction to only one light chain type and absence of T cell antigens. The growth fraction was 5% to 30%, as shown with the monoclonal antibody Ki-67. The immunoarchitecture of the tumors in three patients was unusual compared with established criteria for cutaneous B cell lymphoma and revealed similarities to mucosa-associated B cell lymphoma. Some immunohistologic heterogeneity may indicate the development of monoclonal proliferation that originated from different phases of B lymphocytic differentiation. In three cases no clinical signs of B. burgdorferi infection were found; in one patient acrodermatitis chronica atrophicans was present. The occurrence of acrodermatitis chronica atrophicans and malignant lymphomas was frequently reported in the European literature before B. burgdorferi was recognized. These findings suggest a relation between B. burgdorferi infection and cutaneous B cell lymphoma. In geographic regions where infected ticks are present, borreliosis should be considered in patients with cutaneous B cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033136     DOI: 10.1016/0190-9622(91)70088-j

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  18 in total

1.  Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas.

Authors:  Maurilio Ponzoni; Andrés J M Ferreri; Silvia Mappa; Elisa Pasini; Silvia Govi; Fabio Facchetti; Daniele Fanoni; Alessandra Tucci; Arianna Vino; Claudio Doglioni; Emilio Berti; Riccardo Dolcetti
Journal:  Oncologist       Date:  2011-11-09

2.  Primary cutaneous marginal zone B-cell lymphoma (PCMZL-MALT).

Authors:  U Bohn-Sarmiento; D Aguiar-Bujanda; J Aguiar-Morales; M A Cabrera-Suárez
Journal:  Clin Transl Oncol       Date:  2006-07       Impact factor: 3.405

3.  A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.

Authors:  Mark P Purdue; Qing Lan; Sophia S Wang; Anne Kricker; Idan Menashe; Tong-Zhang Zheng; Patricia Hartge; Andrew E Grulich; Yawei Zhang; Lindsay M Morton; Claire M Vajdic; Theodore R Holford; Richard K Severson; Brian P Leaderer; James R Cerhan; Meredith Yeager; Wendy Cozen; Kevin Jacobs; Scott Davis; Nathaniel Rothman; Stephen J Chanock; Nilanjan Chatterjee; Bruce K Armstrong
Journal:  Carcinogenesis       Date:  2008-11-24       Impact factor: 4.944

Review 4.  When human cells meet bacteria: precision medicine for cancers using the microbiota.

Authors:  Han Zhang; Litao Sun
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

Review 5.  Marginal Zone Lymphoma: State-of-the-Art Treatment.

Authors:  Ariel Sindel; Taha Al-Juhaishi; Victor Yazbeck
Journal:  Curr Treat Options Oncol       Date:  2019-12-05

6.  Intracranial pseudolymphoma.

Authors:  A Donnet; N Horschowski; H Dufour; D Figarella-Branger; P A Bryon; F Berger; J R Harle; F Grisoli
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

7.  Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci.

Authors:  Manuel F Rosado; Gerald E Byrne; Feying Ding; Kenneth A Fields; Phillip Ruiz; Sander R Dubovy; Gale R Walker; Arnold Markoe; Izidore S Lossos
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

Review 8.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

9.  [Cutaneous marginal zone lymphoma (SALT) and infection with Borrelia burgdorferi].

Authors:  M Fühler; K W Ottmann; M Tronnier
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

10.  Borrelia infection and risk of non-Hodgkin lymphoma.

Authors:  Claudia Schöllkopf; Mads Melbye; Lars Munksgaard; Karin Ekström Smedby; Klaus Rostgaard; Bengt Glimelius; Ellen T Chang; Göran Roos; Mads Hansen; Hans-Olov Adami; Henrik Hjalgrim
Journal:  Blood       Date:  2008-04-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.